Related Experiment Video
Updated: Jul 31, 2026

06:02
Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model
Published on: July 26, 2011
Ceruloplasmin immunoreactivity in neurodegenerative disorders
D A Loeffler1, A A Sima, P A LeWitt
1Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI 48201, USA. aa2690@hotmail.com
Free Radical Research
|November 8, 2001
Summary
Ceruloplasmin (CP) may act as a brain antioxidant. Alzheimer's disease brains show increased neuronal CP, particularly in the hippocampus, suggesting a role in neuroprotection.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Ceruloplasmin (CP) is a serum cuproprotein crucial for antioxidant defense.
- Hereditary CP deficiency is linked to iron deposition and lipid peroxidation in the brain.
- The potential antioxidant role of CP within the central nervous system requires further investigation.
Purpose of the Study:
- To compare CP immunoreactivity in brain specimens from controls and patients with neurodegenerative diseases.
- To investigate the distribution and intensity of neuronal CP staining in various brain regions.
- To explore the association between CP levels and neurodegenerative conditions like Alzheimer's disease.
Main Methods:
- Immunohistochemical analysis of CP in post-mortem brain tissue from normal controls and patients with Alzheimer's disease, Parkinson's disease, progressive supranuclear palsy, and Huntington's disease.
- Quantification of neuronal CP staining intensity and the number of CP-stained neurons in specific brain regions (hippocampus, cortex, substantia nigra, caudate).
- Statistical comparison of CP levels between disease groups and controls.
Main Results:
- CP was detected in neurons and astrocytes across all examined brain specimens.
- A statistically significant increase in neuronal CP staining intensity was observed in the CA1 region of the hippocampus in Alzheimer's disease patients compared to controls.
- Slight, non-significant increases in neuronal CP staining were noted in other neurodegenerative disorders, with no significant differences in the number of CP-stained neurons per field.
Conclusions:
- The study suggests a modest elevation of neuronal CP content in Alzheimer's disease brains.
- Lesser elevations in neuronal CP may occur in other studied neurodegenerative disorders.
- The precise function of CP as an antioxidant within the brain warrants further research.
More Related Videos
Related Concept Videos
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

